Warfarine is safe after first therapy with low molecular weight heparin in patients with cancer and thrombosis
Cancer patients who develop thrombosis and/or pulmonary embolism can replace their daily injections of low molecular weight heparin with a warfarin pill after the first six months of treatment. That’s what a study done by Dr. Chatree Chai-Adisaksopha, of McMaster...
Hospital practice confirms the findings of clinical trials with new oral anticoagulants
The first results were presented at the 11th VTE Multidisciplinary Forum The 11th VTE Multidisciplinary Forum, held in Valencia on May 7th and 8th, was the setting for the presentation of the first results of the use of rivaroxaban, one of the new oral...
Reconsidering duration of anticoagulant therapy in VTE cases
Researchers from the RIETE group question the usual guidelines, due to the risk of bleeding Knowing until when we should keep anticoagulant therapy in patients who have had a thrombosis is not always easy. That’s what a study done by doctors of the RIETE group...